Full-Time

Cardiac Technician

Confirmed live in the last 24 hours

iRhythm Technologies

iRhythm Technologies

1,001-5,000 employees

Advanced cardiac monitoring solutions provider

Compensation Overview

$66.6k - $80.1k/yr

Junior, Mid

San Francisco, CA, USA

Hybrid position with 2 days/week in-office requirements; candidates must reside within 50 miles of San Francisco, CA.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Requirements
  • At least 1 year experience in healthcare, health insurance or medical device industry or prior experience in patient care, operations, lab setting and/or other diagnostic environment or an Associates degree or college course work in healthcare or life science related industry
  • High School Diploma required
  • PC agility skills and knowledge of Microsoft tools, windows, outlook
  • Successful completion of new hire training requirements
  • Knowledge of medical terminology specific to Cardiology
  • Able to be CCT certified within 120 days of hire (maximum 3 attempts)
  • Excellent attention to detail
  • Positive attitude and team player
  • Ability to use critical thinking skills
  • Demonstrated interest and desire to learn rhythm analysis and interpretation
  • Ability to define problems, collect data, establish facts, and draw valid conclusions
  • Excellent interpersonal, organizational, and communication skills
  • Must be open to continuous feedback for continual growth and development
  • Great work ethic and a desire to provide high quality outcomes (reports) to our clients and patients
Responsibilities
  • Review patient ECG data and algorithm findings for clinical accuracy, ensuring 100% data quality.
  • Effectively communicate ECG abnormalities to physicians as needed.
  • Perform quality assurance for every report, making necessary modifications before final delivery.
  • Continuously develop ECG interpretation skills, meeting productivity and quality metrics.
  • Maintain compliance with HIPAA guidelines and best clinical practices.
  • Read, interpret, and report on 90-second ECG strips with precision.
  • Provide quality assurance on reports for medical professionals and communicate critical findings clearly.
  • Follow up with patients for additional data transmissions.
  • Demonstrate strong ECG rhythm interpretation skills and uphold HIPAA guidelines.
  • Maintain proficiency requirements, ensuring timely certification.
Desired Qualifications
  • 2+ years’ experience as a cardiac telemetry monitor technician, Holter scanner or other position requiring ECG interpretation
  • RN, EMT, Exercise Physiologist, CCT, CRAT, EKG certification, CNA or equivalent training

iRhythm Technologies specializes in cardiac monitoring solutions, primarily through its product, the Zio Patch. This wearable device allows for up to 14 days of continuous heart rhythm tracking, enabling healthcare providers to detect irregular heart rhythms that shorter monitoring periods might miss. Patients who suspect heart issues can use the Zio Patch to monitor their heart activity conveniently, reducing the need for frequent office visits, which is especially important in the current telehealth environment. Healthcare providers, including cardiologists, can integrate the Zio Patch into their practices to enhance diagnostic services. iRhythm generates revenue by selling the Zio Patch and offering data analysis services that provide actionable insights based on the collected heart data. The company's goal is to improve patient outcomes and streamline healthcare workflows in the cardiac health sector.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Francisco, California

Founded

2006

Simplify Jobs

Simplify's Take

What believers are saying

  • iRhythm's European expansion aligns with continuous ECG monitoring guidelines.
  • Growing demand for cardiac monitoring due to rising cardiovascular disease prevalence.
  • Remote patient monitoring trend supports Zio Patch's market potential.

What critics are saying

  • Increased competition from AI-driven cardiac monitoring startups.
  • FDA warning letter may lead to regulatory scrutiny and fines.
  • Shareholder investigation could result in legal challenges and financial liabilities.

What makes iRhythm Technologies unique

  • Zio Patch offers up to 14 days of continuous cardiac monitoring.
  • iRhythm's integration with AI enhances arrhythmia detection accuracy and efficiency.
  • Exclusive license with BioIntelliSense expands iRhythm's product offerings.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Mental Health Support

Hybrid Work Options

Pet Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
Investing.com
Feb 28th, 2025
iRhythm technologies' CBO and CLO Murphy sells $1.79 million in stock

Additionally, iRhythm is expanding internationally, with early launches in Europe and plans to enter the Japanese market in mid-2025.

Yahoo Finance
Jan 13th, 2025
Irhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights And Business Update At The 43Rd Annual J.P. Morgan Healthcare Conference

iRhythmSAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 43rd Annual J.P. Morgan Healthcare Conference.Recent Operational Highlights and Financial OutlookAnticipate full year 2024 revenue slightly above high end of previously stated guidance range of $587.5 million provided in October 2024Record quarter of new account openings for both Zio monitor and Zio AT during the fourth quarter 2024 as well as strong volume contributions from large national accountsLaunched first four health care systems on Epic Aura during the fourth quarter 2024 with broad commercial roll out for Epic health systems across the U.S. beginning in 2025Initiated Zio monitor shipments for home enrollment patients during the fourth quarter 2024Five studies presented at the American Heart Association highlight Zio Monitor’s high patient satisfaction, engagement and compliance with the patient MyZio app and digital tools, health economic impact of early arrhythmia detection in type 2 diabetes and respiratory disease, and AI insights on sleep and activity patterns 1Expect revenue for the full year 2025 of approximately $675 million to $685 million“This past year was a period of significant growth and transformation for iRhythm,” said Quentin Blackford, iRhythm’s President and CEO. “In our core U.S

MarketBeat
Nov 26th, 2024
Dynamic Technology Lab Private Ltd Invests $1.50 Million in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Dynamic Technology Lab Private Ltd invests $1.50 million in iRhythm Technologies, Inc. (NASDAQ:IRTC).

MPO Magazine
Oct 22nd, 2024
iRhythm Earns FDA Nod for Zio AT After Warning Letter

The letter accused iRhythm of violating Federal Food, Drug, and Cosmetic Act rules about labeling, medical device reporting, and quality systems.

Global Tech Times
Sep 20th, 2024
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm

Recently a securities fraud complaint was filed against iRhythm on behalf of investors who purchased shares of the company's stock between November 5, 2021 and May 30, 2023 (the "Class Period").